SearchDictionaryMobileLogin

Bengt Winblad Selected Research

Alzheimer Disease (Alzheimer's Disease)

08/2008p70 S6 Kinase and Tau in Alzheimer's Disease.
05/2008Effect of phenserine treatment on brain functional activity and amyloid in Alzheimer's disease.
11/2007A rivastigmine patch for the treatment of Alzheimer's disease and Parkinson's disease dementia.
09/2007The Alzheimer's disease-associated gamma-secretase complex: functional domains in the presenilin 1 protein.
06/2007Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study.
05/2007A six-month double-blind, randomized, placebo-controlled study of a transdermal patch in Alzheimer's disease--rivastigmine patch versus capsule.
05/2007Occludin is overexpressed in Alzheimer's disease and vascular dementia.
05/2007Caregiver preference for rivastigmine patch relative to capsules for treatment of probable Alzheimer's disease.
01/2007Effects of statins on cognitive function in patients with Alzheimer's disease in galantamine clinical trials.
01/2007Memantine in moderate to severe Alzheimer's disease: a meta-analysis of randomised clinical trials.
06/2006Altered subcellular localization of ornithine decarboxylase in Alzheimer's disease brain.
04/2006Donepezil in patients with severe Alzheimer's disease: double-blind, parallel-group, placebo-controlled study.
08/2005Levels of mTOR and its downstream targets 4E-BP1, eEF2, and eEF2 kinase in relationships with tau in Alzheimer's disease brain.
02/2005Biomarkers for apoptosis in Alzheimer's disease.
01/2005Characterization of the Alzheimer's disease-associated CLAC protein and identification of an amyloid beta-peptide-binding site.
12/2004APOE genotype, family history of dementia, and Alzheimer disease risk: a 6-year follow-up study.
11/2004Serum lipids and hippocampal volume: the link to Alzheimer's disease?
08/2004Impact of donepezil treatment for Alzheimer's disease on caregiver time.
04/2004Long-term treatment of Alzheimer disease: efficacy and safety of acetylcholinesterase inhibitors.
01/2004Changes in the levels of cerebral and extracerebral sterols in the brain of patients with Alzheimer's disease.
11/2003Molecular identification of AMY, an Alzheimer disease amyloid-associated protein.
09/2003Okadaic-acid-induced inhibition of protein phosphatase 2A produces activation of mitogen-activated protein kinases ERK1/2, MEK1/2, and p70 S6, similar to that in Alzheimer's disease.
08/2003Up-regulation of phosphorylated/activated p70 S6 kinase and its relationship to neurofibrillary pathology in Alzheimer's disease.
05/2003Amyloid beta pathology in Alzheimer's disease and schizophrenia.
02/2003No association between polymorphisms in the neprilysin promoter region and Swedish Alzheimer's disease patients.
01/2003An economic evaluation of donepezil in mild to moderate Alzheimer's disease: results of a 1-year, double-blind, randomized trial.
01/2003Resource utilisation and cost analysis of memantine in patients with moderate to severe Alzheimer's disease.
12/2002Up-regulation of mitogen-activated protein kinases ERK1/2 and MEK1/2 is associated with the progression of neurofibrillary degeneration in Alzheimer's disease.
01/2002Assessment of Health Economics in Alzheimer's Disease (AHEAD): treatment with galantamine in Sweden.

Articles by Research Topic

Disease

29Alzheimer Disease (Alzheimer's Disease)
08/2008 - 01/2002
3Dementia (Dementias)
11/2007 - 09/2003
3Brain Ischemia (Cerebral Ischemia)
02/2006 - 07/2004
2Parkinson Disease (Parkinson's Disease)
11/2007 - 06/2007
2Neuroblastoma
04/2005 - 03/2005
2Experimental Autoimmune Neuritis
02/2004 - 07/2002
1Gliosis
02/2008
1Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy)
05/2007
1Schizophrenia (Dementia Praecox)
05/2003

Drug/Important Bio-Agent (IBA)

4Amyloid (Amyloid Fibrils)IBA
05/2008 - 05/2003
4rivastigmine (Exelon)FDA LinkGeneric
11/2007 - 05/2007
370-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA
08/2008 - 08/2003
3Memantine (Namenda)FDA Link
01/2007 - 01/2003
3donepezil (Aricept)FDA LinkGeneric
04/2006 - 01/2003
2Galantamine (Galanthamine)IBA
01/2007 - 01/2002
2alpha-MSHIBA
02/2006 - 01/2005
2ZincIBA
04/2005 - 03/2005
2AntigensIBA
02/2004 - 07/2002
2Mitogen-Activated Protein KinasesIBA
09/2003 - 12/2002
1phenserineIBA
05/2008
1Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
02/2008
1Presenilin-1IBA
09/2007
1Amyloid Precursor Protein Secretases (beta-Secretase)IBA
09/2007
1mitochondrial transcription factor AIBA
06/2007
1occludinIBA
05/2007
1Ornithine Decarboxylase (Decarboxylase, Ornithine)IBA
06/2006
1Phosphotransferases (Kinase)IBA
08/2005
1Mitogen-Activated Protein Kinase 3IBA
04/2005
1Glycogen Synthase KinasesIBA
03/2005
1Biological Markers (Surrogate Marker)IBA
02/2005
1Apolipoproteins E (ApoE)IBA
12/2004
1LipidsIBA
11/2004
1Interleukin-1 (Interleukin 1)IBA
07/2004
1Cholinesterase Inhibitors (Anticholinesterases)IBA
04/2004
1ApolipoproteinsIBA
02/2004
1SterolsIBA
01/2004
1Okadaic AcidIBA
09/2003
1Protein Phosphatase 2 (Protein Phosphatase 2A)IBA
09/2003
1Neprilysin (Neutral Endopeptidase)IBA
02/2003
1Interleukin-18 (Interleukin 18)IBA
07/2002
1AntibodiesIBA
07/2002